| Registration number: |
E015583 |
| European Patent number: |
EP2889033 |
| Application number: |
EP15151165.6 |
| Filing date of the application: |
19.11.2009 |
| Date of the grant of the European patent: |
21.03.2018 |
| Date of the publication of the translation: |
15.08.2018 |
| Status: |
Lapsed |
| Fees paid for the years of validity: |
11 |
| IPC class: |
A61K 31/439
A61P 25/00
|
| Examiner: |
Kadi Roosenbaum
|
| Owner: |
Forum Pharmaceuticals Inc. |
| Patent attorney: |
Harald Tehver |
| Estonian title |
Skisofreenia negatiivsete sümptomite ravi (R)-7-kloro-N-(kinuklidiin-3-üül)benso[b]tiofeen-2-karboksamiidi ja selle farmatseutiliselt vastuvõetavate sooladega |
| Translation of the patent specification:
|
Display translation of the patent specification
|
| |
|
| Display: |
EXAMINATION |
DATA OF THE FEES |
